C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma.
about
Molecular Testing of Brain Tumor.Chemotherapy for intracranial ependymoma in adultsPituitary Ependymoma, 10-Year Follow-Up after Partial Resection and Radiation Therapy.TERT Promoter Mutations but not the Alternative Lengthening of Telomeres Phenotype Are Present in a Subset of Ependymomas and Are Associated With Adult Onset and Progression to Ependymosarcoma.
P2860
C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
C11orf95-RELA fusion present i ...... ndymoma and recurrent sarcoma.
@ast
C11orf95-RELA fusion present i ...... ndymoma and recurrent sarcoma.
@en
type
label
C11orf95-RELA fusion present i ...... ndymoma and recurrent sarcoma.
@ast
C11orf95-RELA fusion present i ...... ndymoma and recurrent sarcoma.
@en
prefLabel
C11orf95-RELA fusion present i ...... ndymoma and recurrent sarcoma.
@ast
C11orf95-RELA fusion present i ...... ndymoma and recurrent sarcoma.
@en
P2093
P2860
P1476
C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma
@en
P2093
Adriana Olar
David Cachia
Ian E McCutcheon
Kenneth D Aldape
Khalida Wani
Mark R Gilbert
Marta Penas-Prado
Robert S Benjamin
P2860
P2888
P304
P356
10.1007/S10014-014-0205-1
P577
2014-11-12T00:00:00Z